Rilemo

Rilemo

Real-time neuroimaging for anyone, anywhere

Recently at SMAU London 2026

Start-up of ITA - Italian Trade Agency

Start-up

Don Sebastiano Colleoni,  20
Robbiate  (Lecco) — 23899 — Italia

Description

Rilemo is a medtech startup focused on expanding access to neuroimaging beyond traditional hospital settings. The company develops portable brain imaging solutions that enable faster and more informed clinical decisions in time-dependent neurological conditions, allowing clinicians to access imaging information closer to the patient and accelerating time to diagnosis.



Rilemo’s technology combines electromagnetic imaging with advanced AI-based image analysis techniques to generate real-time brain imaging information. The device is portable, non-ionizing, and suitable for repeated use, enabling earlier diagnostic support and helping to reduce delays along acute and emergency neurological care pathways.



By bringing imaging to the point of care, Rilemo supports hospitals, emergency services, and clinical teams managing acute neurological conditions, while also contributing to more efficient care pathways and better utilization of healthcare resources. The solution is designed for use in emergency departments, stroke pathways, and acute care settings, with future applications in decentralized monitoring and community care contexts.



Rilemo's mission is to make real-time neuroimaging accessible everywhere, enabling healthcare systems to evolve toward faster, proactive, and patient-centered diagnostic pathways.



 


Our products

Portable real-time brain imaging system

Portable real-time brain imaging system

Rilemo is developing a portable device for brain imaging that enables real-time neuroimaging directly at the point of care. The system is designed to support faster clinical decision-making in time-dependent neurological conditions, allowing clinicians to access brain imaging information without relying solely on fixed hospital infrastructure, thus accelerating time to diagnosis. The device leverages a patented electromagnetic imaging technology combined with AI-based image analysis developed in-house using proprietary datasets, enabling the generation of clinically useful brain imaging information within seconds. The non-ionizing technology allows for safe and repeatable use, supporting earlier clinical evaluation, reducing diagnostic delays, and improving the efficiency of care pathways in neurological emergencies. Progettato per l’utilizzo in contesti di emergenza e terapia intensiva, il sistema consente di portare l’imaging cerebrale più vicino al paziente, con un potenziale futuro supporto a modelli di monitoraggio decentralizzato e a percorsi di cura neurologica più proattivi.